Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
177M
-
Number of holders
-
111
-
Total 13F shares, excl. options
-
40.3M
-
Shares change
-
-2.88M
-
Total reported value, excl. options
-
$126M
-
Value change
-
-$13.9M
-
Put/Call ratio
-
0.46
-
Number of buys
-
53
-
Number of sells
-
-56
-
Price
-
$3.14
Significant Holders of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) as of Q3 2023
146 filings reported holding OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share as of Q3 2023.
OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) has 111 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40.3M shares
of 177M outstanding shares and own 22.76% of the company stock.
Largest 10 shareholders include Opaleye Management Inc. (6.47M shares), SUMMER ROAD LLC (6.12M shares), BlackRock Inc. (5.34M shares), VANGUARD GROUP INC (4.06M shares), DELTEC ASSET MANAGEMENT LLC (2.06M shares), STATE STREET CORP (1.78M shares), GEODE CAPITAL MANAGEMENT, LLC (1.63M shares), CITADEL ADVISORS LLC (1.29M shares), Nuveen Asset Management, LLC (1.01M shares), and SECTORAL ASSET MANAGEMENT INC (969K shares).
This table shows the top 111 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.